NCT03050398View on ClinicalTrials.gov

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

PHASE3TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

March 8, 2019

Study Completion Date

March 8, 2019

Conditions
Breast Cancer
Interventions
DRUG

Ribociclib

ribociclib + letrozole

DRUG

letrozole

ribociclib + letrozole

Trial Locations (6)

28207

Oncology Speciialists of Charlotte, Charlotte

29506

McLeod Center for Cancer Treatment and Research, Florence

29732

Carolina Blood and Cancer Care of South Carolina, Rock Hill

86336

Arizona Oncology Associates PC HAL, Sedona

90813

Pacific Shores Medical Group SC, Long Beach

98225

PeaceHealth St Joseph Medical Center, Bellingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY